- Allē Members Can Celebrate with Double Points and Enter for
a Chance to Win $5,000
IRVINE,
Calif., June 6, 2024 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), the makers of
BOTOX® Cosmetic (onabotulinumtoxinA), is celebrating 25
years of SkinMedica®. To mark this milestone
anniversary, Allē Members who purchase
SkinMedica® products at a participating Allē Health
Care Provider or SkinMedica.com from June 1 to June 25, 2024 can earn double points*
and enter for a chance to win $5,000.**
"For 25 years, SkinMedica® has been delivering
scientifically based skincare to patients and helping them to
unlock the potential to have beautiful skin," said Jasson Gilmore, Senior Vice President of U.S.
Aesthetics at Allergan Aesthetics. "We want to thank everyone who
is a part of the SkinMedica® family from its
founders to our scientists, our employees, our customers and of
course, everyone who uses SkinMedica®!"
Since 1999, SkinMedica® has developed high-quality,
science-backed formulas that deliver visible results. The initial
product launch of Dermal Repair Cream was soon followed by the
groundbreaking TNS Recovery Complex®, TNS Essential
Serum®, and TNS® Advanced+ Serum,
establishing the brand as a fixture in the industry. Throughout its
evolution, SkinMedica® would continue to introduce
new, innovative formulations to SkinMedica® loyalists
and newcomers for years to come.
"Twenty-five years ago, we founded SkinMedica® with a
vision—to create a skincare line that's both scientific and
luxurious, yet easy to use," reflected Dr. Kimberly Butterwick, a double board-certified
dermatologist and SkinMedica® co-founder. "Our
breakthrough TNS® product, developed through a
unique process that harnessed growth factors, transformed
SkinMedica® from a startup into a brand known for
innovation and excellence."
"Beautiful skin is timeless," Dr. Butterwick continues. "For 25
years, SkinMedica® has helped people feel more
confident in their own skin, and I continue to count on them to
provide science-based solutions to address my patients' key
skincare concerns. As we celebrate this anniversary, I look forward
to seeing how SkinMedica® continues to innovate and
provide exceptional skincare in the next 25 years."
Follow @SkinMedica on Instagram to stay updated on exciting
25th anniversary promotions this month. Use the hashtag
#25YearsOfSkinMedica to join in on the celebrations and share your
SkinMedica® skincare journey. To learn more about the
SkinMedica® range of exceptional products, visit
SkinMedica.com.
*Terms and conditions apply to the double points offer.
**NO PURCHASE NECESSARY for sweepstakes. Open to Allē
Members in 50 U.S./D.C.; age 18+ (19+ in AL & NE; 21+ in MS).
Starts at 12:00:01 AM PT on 6/1/24;
ends at 11:59:59 PM PT on 6/25/24.
Allē Members must be logged into their Allē account if purchasing
from SkinMedica.com or a Brilliant Connections™ online retailer for
such purchases to be eligible for this promotion. See full
Official Rules for all details and how to enter without purchase at
https://alle.com/sweeps/skinmedica-25th-celebration. Sponsor:
Allergan, Inc.
About Allergan Aesthetics
At Allergan Aesthetics, an
AbbVie company, we develop, manufacture, and market a portfolio of
leading aesthetics brands and products. Our aesthetics portfolio
includes facial injectables, body contouring, plastics, skin care,
and more. Our goal is to consistently provide our customers with
innovation, education, exceptional service, and a commitment to
excellence, all with a personal touch. For more information, visit
www.allerganaesthetics.com
About AbbVie
AbbVie's mission is to discover and
deliver innovative medicines and solutions that solve serious
health issues today and address the medical challenges of tomorrow.
We strive to have a remarkable impact on people's lives across
several key therapeutic areas – immunology, oncology, neuroscience,
and eye care – and products and services in our Allergan Aesthetics
portfolio. For more information about AbbVie, please visit us at
www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X
(formerly Twitter), and YouTube.
Forward-Looking Statements
Some statements in this news release are, or may be considered,
forward-looking statements for purposes of the Private Securities
Litigation Reform Act of 1995. The words "believe," "expect,"
"anticipate," "project" and similar expressions and uses of future
or conditional verbs, generally identify forward-looking
statements. AbbVie cautions that these forward-looking statements
are subject to risks and uncertainties that may cause actual
results to differ materially from those expressed or implied in the
forward-looking statements. Such risks and uncertainties include,
but are not limited to, challenges to intellectual property,
competition from other products, difficulties inherent in the
research and development process, adverse litigation or government
action, and changes to laws and regulations applicable to our
industry. Additional information about the economic, competitive,
governmental, technological and other factors that may affect
AbbVie's operations is set forth in Item 1A, "Risk Factors," of
AbbVie's 2023 Annual Report on Form 10-K, which has been filed with
the Securities and Exchange Commission, as updated by its
subsequent Quarterly Reports on Form 10-Q. AbbVie undertakes no
obligation, and specifically declines, to release publicly any
revisions to forward-looking statements as a result of subsequent
events or developments, except as required by law.
BOTOX® COSMETIC IMPORTANT SAFETY INFORMATION AND
APPROVED USES
Approved Uses
BOTOX® Cosmetic is a
prescription medicine that is injected into muscles and used to
temporarily improve the look of moderate to severe forehead lines,
crow's feet lines, and frown lines between the eyebrows in
adults.
IMPORTANT SAFETY INFORMATION
BOTOX®
Cosmetic may cause serious side effects that can be life
threatening. Get medical help right away if you have any of these
problems any time (hours to weeks) after injection of
BOTOX® Cosmetic:
- Problems swallowing, speaking, or breathing, due to
weakening of associated muscles, can be severe and result in loss
of life. You are at the highest risk if these problems are
pre-existing before injection. Swallowing problems may last for
several months.
- Spread of toxin effects. The effect of botulinum
toxin may affect areas away from the injection site and cause
serious symptoms including: loss of strength and all-over muscle
weakness, double vision, blurred vision and drooping eyelids,
hoarseness or change or loss of voice, trouble saying words
clearly, loss of bladder control, trouble breathing, and trouble
swallowing.
BOTOX® Cosmetic dosing units are not the same as,
or comparable to, any other botulinum toxin product.
There has not been a confirmed serious case of spread of toxin
effect when BOTOX® Cosmetic has been used at the
recommended dose to treat frown lines, crow's feet lines, and/or
forehead lines.
BOTOX® Cosmetic may cause loss of strength or general
muscle weakness, vision problems, or dizziness within hours to
weeks of taking BOTOX® Cosmetic. If this happens, do
not drive a car, operate machinery, or do other dangerous
activities.
Serious and/or immediate allergic reactions have been
reported. They include: itching, rash, red itchy welts,
wheezing, asthma symptoms, or dizziness or feeling faint. Get
medical help right away if you are wheezing or have asthma
symptoms, or if you become dizzy or faint.
Do not receive BOTOX® Cosmetic if
you: are allergic to any of the ingredients in
BOTOX® Cosmetic (see Medication Guide for ingredients);
had an allergic reaction to any other botulinum toxin product such
as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), or
Xeomin® (incobotulinumtoxinA); have a skin
infection at the planned injection site.
Tell your doctor about all your muscle or nerve
conditions, such as ALS or Lou
Gehrig's disease, myasthenia gravis, or Lambert-Eaton
syndrome, as you may be at increased risk of serious side effects
including difficulty swallowing and difficulty breathing from
typical doses of BOTOX® Cosmetic.
Tell your doctor about all your medical
conditions, including: plans to have surgery; had surgery
on your face; have trouble raising your eyebrows; drooping eyelids;
any other abnormal facial change; are pregnant or plan to become
pregnant (it is not known if BOTOX® Cosmetic can harm
your unborn baby); are breast-feeding or plan to (it is not known
if BOTOX® Cosmetic passes into breast milk).
Tell your doctor about all the medicines you
take, including prescription and over-the-counter
medicines, vitamins, and herbal supplements. Using
BOTOX® Cosmetic with certain other medicines may cause
serious side effects. Do not start any new medicines until you have
told your doctor that you have received BOTOX® Cosmetic
in the past.
Tell your doctor if you have received any other botulinum toxin
product in the last 4 months; have received injections of botulinum
toxin such as Myobloc®, Dysport®, or
Xeomin® in the past (tell your doctor exactly which
product you received); have recently received an antibiotic by
injection; take muscle relaxants; take an allergy or cold medicine;
take a sleep medicine; take aspirin-like products or blood
thinners.
Other side effects of BOTOX® Cosmetic
include: dry mouth; discomfort or pain at the injection
site; tiredness; headache; neck pain; and eye problems: double
vision, blurred vision, decreased eyesight, drooping eyelids and
eyebrows, swelling of your eyelids and dry eyes.
For more information refer to the Medication Guide or talk with
your doctor.
To report a side effect, please call Allergan at
1-800-678-1605.
Please see BOTOX® Cosmetic full
Product Information including Boxed
Warning and Medication Guide.
SkinMedica® Important Information
Most SkinMedica® products are intended to meet the
FDA's definition of a cosmetic product, an article applied to the
human body to cleanse, beautify, promote attractiveness, and alter
appearances. These SkinMedica® products are not intended
to be drug products that diagnose, treat, cure, or prevent any
disease or condition. These products have not been approved by the
FDA and the statements have not been evaluated by the
FDA.
For more information, please talk to your provider or visit
SkinMedica.com. To report an adverse reaction, please call
Allergan at 1-800-433-8871.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/skinmedica-celebrates-25-years-of-empowering-radiant-skin-302165354.html
SOURCE AbbVie